Alaunos Therapeutics, Inc. Annual Depreciation in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Alaunos Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2015 to 2023.
  • Alaunos Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $2K, a 99.7% decline year-over-year.
  • Alaunos Therapeutics, Inc. annual Depreciation for 2023 was $2.32M, a 16.1% decline from 2022.
  • Alaunos Therapeutics, Inc. annual Depreciation for 2022 was $2.76M, a 6.24% increase from 2021.
  • Alaunos Therapeutics, Inc. annual Depreciation for 2021 was $2.6M, a 130% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.32M -$444K -16.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $2.76M +$162K +6.24% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $2.6M +$1.47M +130% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-07
2020 $1.13M +$499K +79.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $629K +$54K +9.39% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
2018 $575K +$206K +55.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $369K +$79K +27.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $290K -$67K -18.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-05
2015 $357K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.